Built to help voters quickly verify how officials vote — district first, party second. All information is sourced from official public records.
HR. 2483 · 119th Congress

SUPPORT for Patients and Communities Reauthorization Act of 2025

Enacted

See what this could mean for your district

Save your district in Account to view district-specific context for this bill.

Bill details

Introduced: 3/31/2025
Status: Became Public Law No: 119-44.
Bill ID: 119hr2483
Latest action: Became Public Law No: 119-44.

Summary

Introduced in House

SUPPORT for Patients and Communities Reauthorization Act of 2025 This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health. For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to • addressing substance use disorders with respect to pregnant and postpartum women, • prevention and recovery from substance use disorders for youth, • housing for individuals in recovery from substance use disorders, • community organizations facilitating recovery from substance use disorders, • loan repayment for certain health care providers treating substance use disorders, • prevention of overdoses of controlled substances, • treatment of children experiencing psychological trauma, and • mental and behavioral health education and training for medical and allied health students. Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support. Additionally, the bill establishes new requirements for HHS, including requirements relating to • protecting the National Suicide Prevention Lifeline program from cybersecurity threats, • establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and • reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Source: BILLSUM · Summary date: 3/31/2025

District impact notes

0 notes

No impact notes have been generated for this bill yet.

These impact notes are AI-generated from official bill metadata/summary as a prototype feature — not official government language.

Tip: impacts are typically generated by the scheduled workflow. If you just ran it, refresh in a minute.

Related votes

Roll calls that reference this bill in official data.

0 roll calls
No related roll calls found yet for this bill.

Primary sources

Official links to verify details. (No interpretation.)

Summary source label: BILLSUM
About this data
  • OurCongress is non-partisan by design. We do not add political interpretation or advocacy.
  • Bill data and official summaries come from GovInfo and Congress.gov. Some bills do not have published summaries yet.
  • District impact notes (when shown) are AI-generated from official bill metadata/summaries to improve readability. They are not official government language.
  • This page updates automatically via a daily ingestion pipeline.

About this data

Non-partisan by design
OurCongress provides plain-English context without endorsements, political interpretation, or advocacy.
Official sources
Data is sourced from official government records (e.g., Congress.gov, GovInfo, Clerk of the House, and the U.S. Senate).
AI-generated text
Some sections may be AI-generated from official summaries/metadata to help readability. AI output can be imperfect—verify with primary sources.
Last updated: 3/31/2025Source: BILLSUMBill: 119hr2483Learn more →